In the original publication [1], there was a mistake in Figures 5 and 8 as published. The mistake is that Figures 5 and 8 are the same, described differently. The corrected Figure 5 and Figure 8 appear below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Figure 5.
Confocal images of the CA1 secondary dendrites in 5 month-old male M-line (a) and 5xFAD-M mice, injected with a physiological solution (b), EDR peptide (c), KED peptide (d). Confocal microscopy, ×100. Scale bar, 10 μm.
Figure 8.
Confocal images of the CA1 secondary dendrites in 5 month-old female M (a) end 5xFAD-M mice injected with a physiological solution (b), EDR peptide (c), KED peptide (d). Confocal microscopy, ×100. Scale bar, 10 μm.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Reference
- 1.Khavinson V., Ilina A., Kraskovskaya N., Linkova N., Kolchina N., Mironova E., Erofeev A., Petukhov M. Neuroprotective Effects of Tripeptides—Epigenetic Regulators in Mouse Model of Alzheimer’s Disease. Pharmaceuticals. 2021;14:515. doi: 10.3390/ph14060515. [DOI] [PMC free article] [PubMed] [Google Scholar]